Nitazoxanide and probiotics for the treatment of recurrent Clostridium difficile infection in a peritoneal dialysis patient

Southern Medical Journal

Volumn 102, Issue 7, 2009, Pages 746-747

  Yangco, Bienvenido G ^a   Sher, Gulab ^a   Bardin, Matthew C ^a  

^a NONE

Author keywords

Clostridium difficile; Dialysis; Nitazoxanide; Peritoneal dialysis; Probiotic

Indexed keywords

METRONIDAZOLE; MOXIFLOXACIN; NITAZOXANIDE; PROBIOTIC AGENT; VANCOMYCIN; ANTIPARASITIC AGENT; THIAZOLE DERIVATIVE;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON FLORA; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LACTOBACILLUS; NAUSEA AND VOMITING; OCCUPATIONAL THERAPY; ORTHOSTATIC HYPOTENSION; PERITONEAL DIALYSIS; PHYSIOTHERAPY; PNEUMONIA; RECURRENT INFECTION; SACCHAROMYCES; TREATMENT DURATION; CLOSTRIDIUM INFECTION; GASTROINTESTINAL DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

ANTIPARASITIC AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PERITONEAL DIALYSIS; PROBIOTICS; THIAZOLES;

EID: 67650290555     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181a82bbb     Document Type: Article

References (8)

1. Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S32-S42.
2. McMaster-Baxter NL, Musher DM. Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy 2007;27:1029-1039.
3. Hecht DW, Galang MA, Sambol SP, et al. In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 2007;51:2716-2719.
4. Musher DM, Logan N, Bressler AM, et al. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis 2009;48:e41-e46.
5. Musher DM, Logan N, Mehendiratta V, et al. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 2007;59:705-710. (Pubitemid 47073405)
6. Rossignol JF. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients. Aliment Pharmacol Ther 2006;24:887-894.
7. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271:1913-1918.
8. Pillai A, Nelson RL. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 2008;1:CD004611. (Pubitemid 351807675)